Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	77.82	80.11	58.76	71.68	85.96	229.59
Short-Term Investments	17.16	92.73	96.61	87.1	63.54	147.32
Trading Asset Securities	21.45	-	14.5	26.83	10.65	29.15
Cash & Short-Term Investments	116.42	172.84	169.87	185.61	160.16	406.05
Cash Growth	-26.07%	1.75%	-8.48%	15.89%	-60.56%	-1.99%
Accounts Receivable	97.29	105.2	88.72	94.89	55.39	62.52
Other Receivables	10.42	8.34	9.51	13.68	12.03	19.53
Receivables	107.71	113.53	98.23	114	69.96	87.15
Inventory	148.65	102.7	91.83	92.49	72.4	56.51
Prepaid Expenses	7.35	7.74	4.88	3.34	2.17	2.21
Other Current Assets	-	-	0.3	0.18	0.29	0.18
Total Current Assets	380.13	396.81	365.12	395.62	304.97	552.1
Property, Plant & Equipment	20.46	20.02	17.86	22.63	29.94	26.16
Long-Term Investments	77.96	103.43	116.36	152.33	174.23	169.79
Goodwill	90.83	86.48	79.84	82.27	75.4	77.73
Other Intangible Assets	384.07	283.61	289.96	338.78	350.3	156.55
Long-Term Deferred Tax Assets	29.1	21.25	19.39	9.31	2.05	2.43
Other Long-Term Assets	55.41	52.2	53.3	50.13	51.28	51.18
Total Assets	1,038	963.8	945.49	1,055	991.89	1,040
Accounts Payable	104.94	78.35	85.37	106.06	65.31	44.51
Short-Term Debt	-	2.12	0.61	1.61	9.19	10.11
Current Portion of Long-Term Debt	18.82	15.37	17.24	16.06	17.48	41.66
Current Portion of Leases	3.39	2.64	1.73	2.58	1.61	1.88
Current Income Taxes Payable	0.31	0.21	1.18	2.27	7.07	13.56
Other Current Liabilities	26.48	12.56	7.9	12.73	4.64	2.34
Total Current Liabilities	153.95	111.25	114.03	141.32	105.3	114.06
Long-Term Debt	78.84	25.9	44.02	52.4	9.27	-
Long-Term Leases	3.69	3.43	5.5	5.05	3.42	2.54
Long-Term Deferred Tax Liabilities	3.05	3.84	2.82	4.37	12.37	21.62
Other Long-Term Liabilities	35.36	24.27	32.26	25.85	19.52	15.22
Total Liabilities	274.89	168.69	198.62	228.98	149.87	153.44
Common Stock	532.64	534.27	540.05	599.06	628.85	694.35
Additional Paid-In Capital	27.89	25.71	25.99	23.66	21.78	18.73
Retained Earnings	144.21	154.79	150.89	161.76	191.65	174.55
Comprehensive Income & Other	58.32	80.34	29.95	41.38	-0.26	-1.39
Total Common Equity	763.06	795.11	746.87	825.86	842.02	886.24
Shareholders' Equity	763.06	795.11	746.87	825.86	842.02	886.24
Total Liabilities & Equity	1,038	963.8	945.49	1,055	991.89	1,040
Total Debt	104.74	49.46	69.09	77.7	40.96	56.19
Net Cash (Debt)	11.68	123.38	108.18	123.08	119.2	365.18
Net Cash Growth	-88.68%	14.04%	-12.10%	3.26%	-67.36%	-23.76%
Net Cash Per Share	0.12	1.22	1.01	1.07	0.96	2.77
Filing Date Shares Outstanding	99.65	100.05	101.17	110.13	117.03	128.76
Total Common Shares Outstanding	99.65	100.05	101.17	112.21	117.78	130.04
Working Capital	226.18	285.57	251.09	254.3	199.67	438.04
Book Value Per Share	7.66	7.95	7.38	7.36	7.15	6.82
Tangible Book Value	288.16	425.02	377.07	404.8	416.32	651.97
Tangible Book Value Per Share	2.89	4.25	3.73	3.61	3.53	5.01
Land	-	0.01	0.93	1.55	1.09	0.89
Buildings	-	18.5	9.84	14.56	7.69	6.3
Machinery	-	42.56	21.91	33.13	25.94	18.16

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.